New vaccine technologies to combat outbreak situations
Ever since the development of the first vaccine more than 200 years ago, vaccinations have
greatly decreased the burden of infectious diseases worldwide, famously leading to the …
greatly decreased the burden of infectious diseases worldwide, famously leading to the …
[HTML][HTML] COVID-19 vaccines: Current status and implication for use in Indonesia
Abstract The coronavirus disease 2019 (COVID-19) has inflicted catastrophic damages in
public health, economic and social stability—putting life globally on hold in 2020 and …
public health, economic and social stability—putting life globally on hold in 2020 and …
Randomized trial of vaccines for Zaire Ebola virus disease
PREVAC Study Team - New England Journal of Medicine, 2022 - Mass Medical Soc
Background Questions remain concerning the rapidity of immune responses and the
durability and safety of vaccines used to prevent Zaire Ebola virus disease. Methods We …
durability and safety of vaccines used to prevent Zaire Ebola virus disease. Methods We …
Ebola virus disease
D Malvy, AK McElroy, H de Clerck, S Günther… - The Lancet, 2019 - thelancet.com
Ebolaviruses are pathogenic agents associated with a severe, potentially fatal, systemic
disease in man and great apes. Four species of ebolaviruses have been identified in west or …
disease in man and great apes. Four species of ebolaviruses have been identified in west or …
Safety and immunogenicity of a 2-dose heterologous vaccine regimen with Ad26. ZEBOV and MVA-BN-Filo Ebola vaccines: 12-month data from a phase 1 …
Abstract Background During the 2014 West African Ebola outbreak, Ebola vaccine
development was accelerated. The phase 1 VAC52150EBL1003 study was performed to …
development was accelerated. The phase 1 VAC52150EBL1003 study was performed to …
Ebola vaccine trials: progress in vaccine safety and immunogenicity
KM Matz, A Marzi, H Feldmann - Expert review of vaccines, 2019 - Taylor & Francis
Introduction: Ebolaviruses are non-segmented negative-strand RNA viruses in the
Filoviridae family that cause a neglected infectious disease designated as Ebola virus …
Filoviridae family that cause a neglected infectious disease designated as Ebola virus …
Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens
A Fathi, C Dahlke, MM Addo - Human vaccines & …, 2019 - Taylor & Francis
The devastating Ebola virus (EBOV) outbreak in West Africa in 2013–2016 has flagged the
need for the timely development of vaccines for high-threat pathogens. To be better …
need for the timely development of vaccines for high-threat pathogens. To be better …
Development of pandemic vaccines: ERVEBO case study
J Wolf, R Jannat, S Dubey, S Troth, MT Onorato… - Vaccines, 2021 - mdpi.com
Preventative vaccines are considered one of the most cost-effective and efficient means to
contain outbreaks and prevent pandemics. However, the requirements to gain licensure and …
contain outbreaks and prevent pandemics. However, the requirements to gain licensure and …
Effectiveness of COVID‑19 vaccines and their challenges
G Marfe, S Perna, AK Shukla - Experimental and …, 2021 - spandidos-publications.com
At the end of 2019, a new disease recognized such as severe acute respiratory syndrome
(SARS), was reported in Wuhan, China. This disease was caused by an unknown SARS …
(SARS), was reported in Wuhan, China. This disease was caused by an unknown SARS …
[HTML][HTML] Use of Ebola vaccine: recommendations of the advisory committee on immunization practices, United States, 2020
MJ Choi - MMWR. Recommendations and Reports, 2021 - cdc.gov
This report summarizes the recommendations of the Advisory Committee on Immunization
Practices (ACIP) for use of the rVSVΔG-ZEBOV-GP Ebola vaccine (Ervebo) in the United …
Practices (ACIP) for use of the rVSVΔG-ZEBOV-GP Ebola vaccine (Ervebo) in the United …